Vir Biotechnology (VIR) Gross Profit (2020 - 2025)

Vir Biotechnology's Gross Profit history runs 6 years deep, the most recent figure standing at $1.2 million for Q2 2025.

• In Q2 2025, Gross Profit fell 60.21% year-over-year to $1.2 million; the TTM figure through Jun 2025 stood at $18.3 million (down 75.08% YoY), while the FY2025 annual figure was $68.5 million, down 6.58% from the prior year.
• Gross Profit came in at $1.2 million for Q2 2025 at Vir Biotechnology, down from $3.0 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $1.1 billion in Q1 2022 to a low of $1.2 million in Q2 2025.
• A 5-year average of $151.5 million and a median of $14.3 million in 2022 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit soared 57709.21% in 2022 and plunged 99.26% in 2023, its largest moves.
• Vir Biotechnology's Gross Profit stood at $755.9 million in 2021, then plunged by 94.26% to $43.4 million in 2022, then tumbled by 63.17% to $16.0 million in 2023, then slipped by 26.89% to $11.7 million in 2024, then plunged by 89.71% to $1.2 million in 2025.
• According to Business Quant data, Gross Profit over the past three periods registered $1.2 million, $3.0 million, and $11.7 million for Q2 2025, Q1 2025, and Q4 2024 respectively.

Peer Comparison